Hemogenyx Restructures Shares to Attract Investors

HemoGenyx Pharmaceuticals Plc (GB:HEMO) has released an update.

Hemogenyx Pharmaceuticals is reorganizing its share structure to attract more institutional investors by increasing the perceived value of its shares. The capital reorganization involves a subdivision and consolidation of shares, aimed at supporting the company’s funding needs for advancing clinical trials of its HEMO-CAR-T therapy. This move is crucial for the company to secure sufficient funding and maintain operational capabilities.

For further insights into GB:HEMO stock, check out TipRanks’ Stock Analysis page.